Shubham pant (17 Ergebnisse)

Paperback. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

Paperback. Zustand: Very Good. No Jacket. Missing dust jacket; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

Paperback. Zustand: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Soft cover. Zustand: New. Cancer is now the fourth leading cause of death in India. So the most pressing question today is-what are you doing to lower your risk? In Food Matters: The Role Your Diet Plays in the Fight Against Cancer, Dr Shubham Pant asks you to 'focus on the mundane solutions'. Oncologist at the MD Anderson Cancer Center, he recommends eating a good diet, staying a healthy weight and other lifestyle interventions to keep cancer at bay. Citing case studies, Dr Pant also suggests how patients diagnosed with and recovering from cancer can best manage their nutritional needs. Intensively researched and featuring simple and delicious recipes, Food Matters tells you everything that you need to know about cancer and diet. …

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Paperback. Zustand: Brand New. 206 pages. 5.00x0.47x8.00 inches. In Stock.

Taschenbuch. Zustand: Neu. Neuware - Cancer is now the fourth leading cause of death in India. So the most pressing question today is-what are you doing to lower your risk In Food Matters: The Role Your Diet Plays in the Fight Against Cancer, Dr Shubham Pant asks you to 'f.

Paperback. Zustand: Brand New. 2nd pap/psc edition. 406 pages. 4.75x5.50x0.75 inches. In Stock.

Taschenbuch. Zustand: Neu. Neuware - Kabir isn't the kind of guy who plans his life. He wakes up late, cracks jokes at the wrong time, and somehow still manages to get by. For him, life is simple-don't overthink, don't overfeel.Naina is the exact opposite. She plans everything. Her career, her future, even her emotions. She doesn't believe in distractions, and she definitely doesn't believe in people like Kabir.So when they're forced to work together, it's not magical. It's messy. They argue, they disagree, and most of the time, they can't stand each other.But somewhere in between all the chaos-long conversations, shared silences, and moments that neither of them planned-something begins to change.What starts as irritation slowly becomes comfort.And then, without warning, it becomes something more.Just when they begin to understand what they mean to each other, things fall apart. Old relationships, family expectations, misunderstandings-everything they tried to ignore comes rushing in. And Naina does what she's always done when things get complicated-she walks away.Kabir, for the first time in his life, doesn't.What follows isn't a perfect love story. It's emotional, confusing, a little dramatic, and very real. It's about two people trying to figure out if love is worth the risk, if timing really matters, and if 'we' is something you choose. or something you grow into.Set between the noise of India and the quiet beauty of Europe, We: A Journey isn't just about falling in love.It's about staying.…

Zustand: new.

Hardcover. Zustand: Brand New. 203 pages. 9.25x6.10x0.75 inches. In Stock.

Zustand: New.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Pancreatic cancer isachallengingandcomplex diseasecharacterized by a dense fibrotic stroma and an immunosuppressive tumor microenvironment.Until recently, there were no predictive biomarkers to personalize selection of targeted or biologic therapies as a part of standard of care treatment. Moreover,theregulatory immune population of cells creates a 'cold', non-immunogenic tumor that is resistanttoimmunotherapies including checkpoint inhibitors. However, in the last few years, there has been substantial progress in our understanding of the role mutations in the pathogenesis of disease leading to increased adoption of germline and next generation sequencing to identify mutations and fusions to optimize selection of therapies and select patients for clinical trials of targeted agents.This book provides a comprehensive, global overview ontherapy forpancreatic cancer, exploringapproved therapiesand focusingon the 'Next' in drug development including molecularly targeted therapy and efforts at 'Drugging the Undruggable': the KRAS mutation. It also addresses efforts at targeting the inhospitable stroma to improve drug delivery to the tumor cells, incorporating ct DNA (liquid biopsies) in the care of patients and recent advances in immunotherapy. Pancreatic Cancer: Current Therapeutics and Future Directionswill illuminate these challenges, review existing therapeutics, and highlight current and future efforts to improve outcomes in this devastating disease. Useful to physicians, fellows, medical students, residents, physician assistants, nurse practitioners, pharmaceutical companies and researchers interested in pancreatic cancer, it will firstexplain management of localized disease includingresectability and adjuvant and neoadjuvant therapies. Targeted therapies including molecular, immunotherapy, stromaand role of ctDNA or 'liquidbiopsies'will be addressed. Finally, the book will explore the important role of pain management,diet andexercisein improving outcomes in pancreatic cancer.…

Zustand: Hervorragend. Zustand: Hervorragend | Sprache: Englisch | Produktart: Bücher | Pancreatic cancer is a challenging and complex disease characterized by a dense fibrotic stroma and an immunosuppressive tumor microenvironment. Until recently, there were no predictive biomarkers to personalize selection of targeted or biologic therapies as a part of standard of care treatment. Moreover, the regulatory immune population of cells creates a ¿cold¿, non-immunogenic tumor that is resistant to immunotherapies including checkpoint inhibitors. However, in the last few years, there has been substantial progress in our understanding of the role mutations in the pathogenesis of disease leading to increased adoption of germline and next generation sequencing to identify mutations and fusions to optimize selection of therapies and select patients for clinical trials of targeted agents.This book provides a comprehensive, global overview on therapy for pancreatic cancer, exploring approved therapies and focusing on the ¿Next¿ in drug development including molecularly targeted therapy and efforts at ¿Drugging the Undruggable¿: the KRAS mutation. It also addresses efforts at targeting the inhospitable stroma to improve drug delivery to the tumor cells, incorporating ct DNA (liquid biopsies) in the care of patients and recent advances in immunotherapy. Pancreatic Cancer: Current Therapeutics and Future Directions will illuminate these challenges, review existing therapeutics, and highlight current and future efforts to improve outcomes in this devastating disease. Useful to physicians, fellows, medical students, residents, physician assistants, nurse practitioners, pharmaceutical companies and researchers interested in pancreatic cancer, it will first explain management of localized disease including resectability and adjuvant and neoadjuvant therapies. Targeted therapies including molecular, immunotherapy, stroma and role of ctDNA or ¿liquidbiopsies¿ will be addressed. Finally, the book will explore the important role of pain management, diet and exercise in improving outcomes in pancreatic cancer.…

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Pancreatic cancer isachallengingandcomplex diseasecharacterized by a dense fibrotic stroma and an immunosuppressive tumor microenvironment.Until recently, there were no predictive biomarkers to personalize selection of targeted or biologic therapies as a part of standard of care treatment. Moreover,theregulatory immune population of cells creates a 'cold', non-immunogenic tumor that is resistanttoimmunotherapies including checkpoint inhibitors. However, in the last few years, there has been substantial progress in our understanding of the role mutations in the pathogenesis of disease leading to increased adoption of germline and next generation sequencing to identify mutations and fusions to optimize selection of therapies and select patients for clinical trials of targeted agents.This book provides a comprehensive, global overview ontherapy forpancreatic cancer, exploringapproved therapiesand focusingon the 'Next' in drug development including molecularly targeted therapy and efforts at 'Drugging the Undruggable': the KRAS mutation. It also addresses efforts at targeting the inhospitable stroma to improve drug delivery to the tumor cells, incorporating ct DNA (liquid biopsies) in the care of patients and recent advances in immunotherapy. Pancreatic Cancer: Current Therapeutics and Future Directionswill illuminate these challenges, review existing therapeutics, and highlight current and future efforts to improve outcomes in this devastating disease. Useful to physicians, fellows, medical students, residents, physician assistants, nurse practitioners, pharmaceutical companies and researchers interested in pancreatic cancer, it will firstexplain management of localized disease includingresectability and adjuvant and neoadjuvant therapies. Targeted therapies including molecular, immunotherapy, stromaand role of ctDNA or 'liquidbiopsies'will be addressed. Finally, the book will explore the important role of pain management,diet andexercisein improving outcomes in pancreatic cancer.…

Hardcover. Zustand: gut. 2023. Pancreatic Cancer In deutscher Sprache. pages.